Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123123 · ClinicalTrials.gov registry record · Phase 2
Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients
A Phase 2 study of Pneumonia, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 2
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT00123123 is a Phase 2 study of Pneumonia that has completed, run by State University of New York at Buffalo. The registered enrollment target is 175 participants, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00123123, a Phase 2 study of Pneumonia, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent studies have found that poor oral hygiene may foster the colonization of the oropharynx by potential respiratory pathogens in mechanically-ventilated (MV), intensive care unit (ICU) patients. Thus, improvements in oral hygiene in MV-ICU patients may prevent ventilator-associated pneumonia (VAP). The specific aims of this investigation are: 1) to organize the necessary infrastructure to develop and perform a pilot clinical trial to evaluate alternative oral hygiene procedures to prevent VAP; 2) to use this organization to perform a pilot clinical trial to determine if the use of oral topical chlorhexidine gluconate (CHX) will prevent dental plaque, oropharyngeal colonization by respiratory pathogens, and VAP in MV-ICU patients.
Conditions Studied
Interventions
- DRUG placebo
- DRUG chlorhexidine gluconate oral rinse (0.12%)
Study Locations (1)
New York
- University of Buffalo, The State University of New York - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00123123
The ClinicalTrials.gov registry entry for NCT00123123 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (96% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00123123 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00123123 about?
NCT00123123 is a clinical study titled "Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients". Recent studies have found that poor oral hygiene may foster the colonization of the oropharynx by potential respiratory pathogens in mechanically-ventilated (MV), intensive care unit (ICU) patients. Thus, improvements in oral hygiene in MV-ICU patients may prevent ventilator-associated pneumonia (VA...
What is the current status of trial NCT00123123?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 175 participants. The study started on 2004-03. Estimated completion is 2007-11.
What conditions does trial NCT00123123 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT00123123?
The interventions under investigation include: placebo (DRUG), chlorhexidine gluconate oral rinse (0.12%) (DRUG).
Who is sponsoring clinical trial NCT00123123?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00123123 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Individualizing Corticosteroid Use in Pneumonia
RECRUITING · Phase 2
-
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
RECRUITING · Phase 2
-
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia
ACTIVE NOT RECRUITING · Phase 2
-
Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia
COMPLETED · Phase 2
-
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
COMPLETED · Phase 2
-
A Study of Auxora in Patients With Severe COVID-19 Pneumonia
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.